Progressive Myoclonic Epilepsy Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for Progressive Myoclonic Epilepsy medications. A condition association alone does not establish coverage.
What Is Progressive Myoclonic Epilepsy?
Progressive Myoclonic Epilepsy is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing Progressive Myoclonic Epilepsy with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
About Progressive Myoclonic Epilepsy
Progressive Myoclonic Epilepsy (PME) is a group of rare, inherited neurological disorders characterized by worsening myoclonic seizures and other neurological symptoms. Managing PME often involves lifelong medication, which can be a significant financial burden. TheDrugClub helps individuals and families facing PME afford their essential prescriptions, making treatment more accessible.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What is Progressive Myoclonic Epilepsy?
A heterogeneous group of primarily familial epilepsy disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include Lafora disease; MERRF syndrome; neuronal ceroid-lipofuscinosis; sialidosis (see mucolipidoses), and Unverricht-Lundborg syndrome.
Source: Medical Subject Headings (MeSH), U.S. National Library of Medicine
Capitalization of MeSH cross-references in this definition was adjusted for readability. The U.S. National Library of Medicine does not endorse this change.
This information is educational and is not medical advice.